XML 67 R49.htm IDEA: XBRL DOCUMENT
v3.25.1

Parent-Only Financial Statements (Tables) - Parent [Member] | 12 Months Ended
--- | ---
Dec. 31, 2024
Parent-Only Financial Statements (Tables) [Line Items] |
Schedule of Condensed Balance Sheets | The following represents condensed financial information of the parent company:
|  | As of December 31, |
|  | 2023 |  |  | 2024 |
|  | RMB |  |  | RMB |  |  | US$ |
ASSETS/(LIABILITIES) |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  |  | 1,205,993 |  |  |  | 2,227,649 |  |  |  | 309,895 |
Prepayments |  |  | 13,776 |  |  |  | 891 |  |  |  | 124 |
Due from intercompany |  |  | 456,041,568 |  |  |  | 814,547,651 |  |  |  | 113,314,180 |
Investment in subsidiaries |  |  | (471,994,335 | ) |  |  | (585,987,070 | ) |  |  | (81,518,429 | )
TOTAL ASSETS (LIABILITIES) |  |  | (14,732,998 | ) |  |  | 230,789,121 |  |  |  | 32,105,770 |
SHAREHOLDERS’ EQUITY (DEFICIT) |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity (deficit): |  |  |  |  |  |  |  |  |  |  |  |
Class A ordinary shares ($0.002 par value; 12,141,093 and 14,141,093 shares authorized as of December 31, 2023 and 2024, respectively; 4,192,730 and 13,273,596 shares issued as of December 31, 2023 and 2024, respectively; 3,724,236 and 12,815,143 shares outstanding as of December 31, 2023 and 2024, respectively)* |  |  | 50,106 |  |  |  | 176,842 |  |  |  | 24,601 |
Class B ordinary shares ($0.002 par value; 2,858,909 shares authorized; 2,858,909 shares issued and outstanding as of December 31, 2023 and 2024)* |  |  | 36,894 |  |  |  | 36,894 |  |  |  | 5,132 |
Additional paid-in capital |  |  | 428,310,028 |  |  |  | 780,499,664 |  |  |  | 108,577,662 |
Accumulated deficit |  |  | (452,031,693 | ) |  |  | (565,218,741 | ) |  |  | (78,629,283 | )
Statutory reserves |  |  | 6,647,109 |  |  |  | 6,647,109 |  |  |  | 924,699 |
Accumulated other comprehensive income |  |  | 2,254,558 |  |  |  | 8,647,353 |  |  |  | 1,202,959 |
TOTAL NANO LABS LTD SHAREHOLDERS’ EQUITY (DEFICIT) |  |  | (14,732,998 | ) |  |  | 230,789,121 |  |  |  | 32,105,770 |
* | After giving effect of the reverse stock splits, see Note 12.
Schedule of Condensed Statements of Operations and Comprehensive Income (Loss) |
|  | For the years ended December 31, |
|  | 2022 |  |  | 2023 |  |  | 2024 |
|  | RMB |  |  | RMB |  |  | RMB |  |  | US$ |
Net revenues |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Selling and marketing expenses |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
General and administrative expenses |  |  | 5,822,906 |  |  |  | 471,664 |  |  |  | 683,178 |  |  |  | 95,039 |
Total operating expenses |  |  | 5,822,906 |  |  |  | 471,664 |  |  |  | 683,178 |  |  |  | 95,039 |
Loss from operations |  |  | (5,822,906 | ) |  |  | (471,664 | ) |  |  | (683,178 | ) |  |  | (95,039 | )
Finance income (expense) |  |  | 66,144 |  |  |  | 110,971 |  |  |  | (13,140 | ) |  |  | (1,828 | )
Investment income |  |  | 53,809 |  |  |  | — |  |  |  | — |  |  |  | — |
Income (loss) from investment in subsidiaries |  |  | 36,821,839 |  |  |  | (252,463,079 | ) |  |  | (112,490,730 | ) |  |  | (15,648,925 | )
Net income (loss) attributable to Nano Labs Ltd |  |  | 31,118,886 |  |  |  | (252,823,772 | ) |  |  | (113,187,048 | ) |  |  | (15,745,792 | )
Comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  |  | 31,118,886 |  |  |  | (252,823,772 | ) |  |  | (113,187,048 | ) |  |  | (15,745,792 | )
Other comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  | 4,566,656 |  |  |  | 155,229 |  |  |  | 6,392,795 |  |  |  | 889,320 |
Total comprehensive income (loss) attributable to Nano Labs Ltd |  |  | 35,685,542 |  |  |  | (252,668,543 | ) |  |  | (106,794,253 | ) |  |  | (14,856,472 | )
Schedule of Condensed Statements of Cash Flows |
|  | For the years ended December 31, |
|  | 2022 |  |  | 2023 |  |  | 2024 |
|  | RMB |  |  | RMB |  |  | RMB |  |  | US$ |
Net cash provided by (used in) operating activities |  |  | 3,911,561 |  |  |  | 344,012 |  |  |  | (281,829 | ) |  |  | (39,206 | )
Net cash used in investing activities |  |  | (155,900,936 | ) |  |  | (68,918,960 | ) |  |  | (312,142,434 | ) |  |  | (43,423,075 | )
Net cash provided by financing activities |  |  | 144,043,186 |  |  |  | 72,802,734 |  |  |  | 315,620,394 |  |  |  | 43,906,905 |
Effect of exchange rate changes on cash and cash equivalents |  |  | 7,883,387 |  |  |  | (3,047,562 | ) |  |  | (2,174,475 | ) |  |  | (302,498 | )
Net increase (decrease) in cash and cash equivalents |  |  | (62,802 | ) |  |  | 1,180,224 |  |  |  | 1,021,656 |  |  |  | 142,126 |
Cash and cash equivalents at beginning of the year |  |  | 88,571 |  |  |  | 25,769 |  |  |  | 1,205,993 |  |  |  | 167,769 |
Cash and cash equivalents at end of the year |  |  | 25,769 |  |  |  | 1,205,993 |  |  |  | 2,227,649 |  |  |  | 309,895 |

X
- References No definition available. + Details
Name: | na_ParentOnlyFinancialStatementsTablesLineItems
Namespace Prefix: | na_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |